Skip to main content

Animations

MJFF Publications

5521 - 5530 of 6570 Results
Title
Year
  • Year
  • 2025
  • 2024
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • Summary Details
    OPEN
    Title: Mitofusin 2 displays fusion-independent roles in proteostasis surveillance
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-025-56673-5
    Citation Count: 16
  • Summary Details
    OPEN
    Title: The Amplification of Alpha‐Synuclein Amyloid Fibrils is Suppressed under Fully Quiescent Conditions
    Journal Name: Angewandte Chemie International Edition
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/anie.202419173
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Enhancers active in dopamine neurons are a primary link between genetic variation and neuropsychiatric disease
    Journal Name: Nature Neuroscience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41593-018-0223-0
    Citation Count: 106
  • Summary Details
    OPEN
    Title: Recruitment of patients with de novo Parkinson disease: successful strategies in a randomized exercise clinical trial
    Journal Name: Trials
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13063-018-2958-z
    Citation Count: 13
  • Summary Details
    OPEN
    Title: The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson’s disease
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-018-34490-9
    Citation Count: 160
  • Summary Details
    OPEN
    Title: Distribution of oxidized DJ-1 in Parkinson’s disease-related sites in the brain and in the peripheral tissues: effects of aging and a neurotoxin
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-018-30561-z
    Citation Count: 58
  • Summary Details
    OPEN
    Title: Mapping movement, mood, motivation and mentation in the subthalamic nucleus
    Journal Name: Royal Society Open Science
    Publisher: The Royal Society
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1098/rsos.171177
    Citation Count: 38
  • Summary Details
    OPEN
    Title: Effects of Novel Calpain Inhibitors in Transgenic Animal Model of Parkinson’s disease/dementia with Lewy bodies
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-018-35729-1
    Citation Count: 26
  • Summary Details
    OPEN
    Title: The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/awy215
    Citation Count: 47
  • Summary Details
    OPEN
    Title: Impaired hepatic amyloid-beta degradation in Alzheimer’s disease
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0203659
    Citation Count: 77
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.